Alzheimer’s Drug Startup Korsana Biosciences Raises $175M
Alzheimer’s Drug Development: A Recent Wave of Investment and Innovation Despite the recent approval of two amyloid-targeting therapies for Alzheimer’s disease, investors are continuing to bet on new approaches to tackling the devastating condition. Korsana Biosciences, a newly launched company, has secured $175 million in funding to advance its own amyloid-clearing treatment, KRSA-028. The Persistent … Read more